- Home
- OTLK vs NA Comparison
OTLK vs NA Comparison
Compare OTLK & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OTLK | NA |
|---|---|---|
| Founded | 2010 | 2019 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.8M | 98.5M |
| IPO Year | 2016 | 2022 |
Fundamental Metrics
Financial Performance| Metric | OTLK | NA |
|---|---|---|
| Price | $2.18 | $3.00 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 197.6K |
| Earning Date | 12-24-2025 | 08-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,505,322.00 | ★ $3,369,693.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $342.80 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.79 | $2.75 |
| 52 Week High | $3.39 | $31.48 |
Technical Indicators
Market Signals| Indicator | OTLK | NA |
|---|---|---|
| Relative Strength Index (RSI) | 67.60 | 29.42 |
| Support Level | $1.91 | $2.75 |
| Resistance Level | $2.10 | $3.16 |
| Average True Range (ATR) | 0.15 | 0.28 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 95.65 | 15.24 |
Price Performance
Historical ComparisonAbout OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About NA Nano Labs Ltd
Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.